Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
G42 Healthcare was a leading Abu Dhabi-based health-tech company specializing in the application of artificial intelligence and advanced omics technologies to transform healthcare delivery. It enabled large-scale population genomics initiatives such as the Emirati Genome Program and provided comprehensive diagnostic services including genetic testing for hereditary conditions and early detection screenings for major diseases. In diagnostics rather than therapeutics, so no clinical trial results typical of pharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on G42 Healthcare.